Skip to main content
New Microbes and New Infections logoLink to New Microbes and New Infections
letter
. 2026 Feb 3;70:101719. doi: 10.1016/j.nmni.2026.101719

Recurrent Nipah virus infections: Implications for preparedness and public health response

Kevin Smith P Cabuhat a,b, Christian Joseph N Ong b,c,d,, Jerico B Ogaya e, Don Eliseo Lucero-Prisno III f,g,h, Rich Milton R Dulay b,i
PMCID: PMC12905734  PMID: 41696521

Dear Editor,

The recent re-emergence of Nipah virus (NiV), marked by the tragic death of a 14-year-old boy, underscores the persistent threat posed by zoonotic pathogens and highlights the growing global public health challenge they present [1]. With no licensed vaccine or curative therapy and case-fatality rates reaching 94% in previous outbreaks, NiV remains a critical concern for health authorities worldwide [1,2]. This recurrence emphasizes the urgent need for strengthened outbreak preparedness, robust rapid response strategies, and proactive mitigation measures to limit transmission and reduce morbidity and mortality.

NiV is primarily transmitted through direct contact with infected fruit bats, consumption of contaminated food products, and human-to-human interactions [1,2]. Recent outbreaks in India and Bangladesh have revealed vulnerabilities in public health systems, particularly when atypical respiratory presentations delay diagnosis and containment [3]. Clustering of cases in specific regions, coupled with the emergence of novel genotypes, further complicates control efforts and underscores the necessity of rapid diagnostic capacity, real-time genomic surveillance, and tailored outbreak response strategies that account for local ecological and socio-behavioural contexts [2,3].

Evidence from prior outbreaks demonstrates the effectiveness of coordinated, integrated response measures. In Bangladesh, timely interventions through outbreak investigations, cross-sectoral communication, and evidence-based containment strategies helped limit human-to-human transmission and informed the development of preventive measures (Rahman et al., 2024). Such experiences highlight the importance of collaborative leadership across medical, veterinary, and ecological sectors to implement rapid interventions, enhance risk communication, and support context-specific prevention strategies [1,2,4]. Strengthening healthcare systems, establishing early detection mechanisms, and promoting community awareness are fundamental to reducing outbreak impact and ensuring timely and effective responses [2,3].

Understanding ecological determinants of NiV propagation is equally critical for outbreak prevention. Environmental changes, including deforestation, agricultural expansion, and climate variability, alter bat habitats and increase interactions between reservoir hosts and humans, thereby elevating the risk of zoonotic spillover events [2,5]. Surveillance systems that monitor wildlife reservoirs and human populations, coupled with research on socio-ecological drivers of transmission, enable public health authorities to anticipate and mitigate outbreaks more effectively. Additionally, international collaboration, data sharing, and coordinated capacity-building are essential to strengthen global preparedness and facilitate rapid, evidence-informed interventions [4,5].

Empirical evidence from recent outbreaks highlights the urgency of proactive measures. In Kerala, six confirmed cases, including two fatalities, demonstrate the lethal potential of NiV and underscore the pressing need for vaccines, antivirals, and strengthened healthcare infrastructure [2]. Surveys of healthcare providers reveal gaps in disease-specific knowledge and preparedness, emphasizing the necessity of targeted training, simulation exercises, and frontline capacity-building to ensure effective clinical and public health responses. These findings illustrate that reactive measures alone are insufficient; a combination of proactive research, surveillance, and international collaboration is critical to safeguard populations from emerging zoonotic threats [2,3].

The recurrence of NiV presents a compelling case for immediate, coordinated action. Investments in vaccine development, antiviral therapies, genomic surveillance, and outbreak preparedness are paramount. Rapid dissemination of accurate information and development of context-specific interventions are also essential to prevent transmission, limit fatalities, and strengthen health system resilience. Without timely, multisectoral strategies and global collaboration, the threat posed by NiV and other emerging zoonotic pathogens will continue to challenge public health systems and endanger human lives.

CRediT authorship contribution statement

Kevin Smith P. Cabuhat: Conceptualization, Data curation, Formal analysis, Investigation. Christian Joseph N. Ong: Conceptualization, Data curation, Formal analysis, Investigation. Jerico B. Ogaya: Investigation, Writing – original draft. Don Eliseo Lucero-Prisno: III, Validation, Supervision, Writing – review & editing. Rich Milton R. Dulay: Writing – review & editing, Supervision, Validation.

Ethical approval and consent to participate

Not applicable.

Availability of data

Not applicable.

Consent for publication

Not applicable.

Funding

None.

Declaration of competing interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgement

None.

Contributor Information

Kevin Smith P. Cabuhat, Email: kevin_smith_cabuhat@email.lcup.edu.ph.

Christian Joseph N. Ong, Email: christian_joseph_ong@dlsu.edu.ph.

Jerico B. Ogaya, Email: jericoogaya13@gmail.com.

Don Eliseo Lucero-Prisno, III, Email: don-eliseo.lucero-prisno@lshtm.ac.uk.

Rich Milton R. Dulay, Email: richmiltondulay@clsu.edu.ph.

References

  • 1.Branda F., Ceccarelli G., Giovanetti M., Albanese M., Binetti E., Ciccozzi M., Scarpa F. Nipah virus: a zoonotic threat re-emerging in the wake of global public health challenges. Microorganisms. 2025;13(1):124. doi: 10.3390/microorganisms13010124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Safdar M., Rehman S.U., Younus M., Rizwan M.A., Kaleem M., Ozaslan M. One Health approach to Nipah virus prevention; [Un enfoque de salud para la prevención del virus Nipah] Vacunas. 2024;25(2):264–273. [Google Scholar]
  • 3.Sanker V., Vellekkat F., Dave T. Nipah virus outbreaks in Kerala: an impending doom? Health Sci Rep. 2024;7(11) doi: 10.1002/hsr2.70195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Rahman M., Rimi N.A., Sultana R., Homaira N., Epstein J.H., Luby S.P. Sustainable Development Goals Series (Part F4029. Springer; 2024. Nipah outbreak investigation in Bangladesh, 2007: a case study of one health partnership and intersectoral coordination; pp. 209–222. [Google Scholar]
  • 5.Mishra V.H., Bankar N.J., Tiwari A.P., Noman O., Bandre G.R. Emerging zoonotic viral diseases in India: one Health perspective. J Pure Appl Microbiol. 2025;19(1):34–48. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Not applicable.


Articles from New Microbes and New Infections are provided here courtesy of Elsevier

RESOURCES